Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-26

FDA Approved: DOCOSANOL — Original Application (YYBA Corp)

View source ↗

Summary

The FDA approved an original application (ANDA) for docosanol from YYBA Corp, authorizing the marketing of a generic docosanol product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Docosanol (docosanol)

Snippet

ORIG AP for DOCOSANOL (DOCOSANOL)